209 related articles for article (PubMed ID: 11449876)
1. Levetiracetam.
Nash EM; Sangha KS
Am J Health Syst Pharm; 2001 Jul; 58(13):1195-9. PubMed ID: 11449876
[TBL] [Abstract][Full Text] [Related]
2. Levetiracetam. A review of its adjunctive use in the management of partial onset seizures.
Dooley M; Plosker GL
Drugs; 2000 Oct; 60(4):871-93. PubMed ID: 11085199
[TBL] [Abstract][Full Text] [Related]
3. An assessment of levetiracetam as an anti-epileptic drug.
Jain KK
Expert Opin Investig Drugs; 2000 Jul; 9(7):1611-24. PubMed ID: 11060765
[TBL] [Abstract][Full Text] [Related]
4. Spotlight on levetiracetam in epilepsy.
Lyseng-Williamson KA
CNS Drugs; 2011 Oct; 25(10):901-5. PubMed ID: 21936590
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of levetiracetam.
Radtke RA
Epilepsia; 2001; 42 Suppl 4():24-7. PubMed ID: 11564121
[TBL] [Abstract][Full Text] [Related]
6. Levetiracetam in refractory pediatric epilepsy.
Wheless JW; Ng YT
J Child Neurol; 2002 Jun; 17(6):413-5. PubMed ID: 12174960
[TBL] [Abstract][Full Text] [Related]
7. Levetiracetam: a novel antiepileptic drug.
Hovinga CA
Pharmacotherapy; 2001 Nov; 21(11):1375-88. PubMed ID: 11714211
[TBL] [Abstract][Full Text] [Related]
8. [Levetiracetam: an anti-epileptic drug with interesting pharmacokinetic properties].
Wagner GL; Wilms EB; Vecht ChJ
Ned Tijdschr Geneeskd; 2002 Jun; 146(26):1218-21. PubMed ID: 12132136
[TBL] [Abstract][Full Text] [Related]
9. Levetiracetam: treatment in epilepsy.
Ben-Menachem E
Expert Opin Pharmacother; 2003 Nov; 4(11):2079-88. PubMed ID: 14596661
[TBL] [Abstract][Full Text] [Related]
10. Levetiracetam: a review of its use in epilepsy.
Lyseng-Williamson KA
Drugs; 2011 Mar; 71(4):489-514. PubMed ID: 21395360
[TBL] [Abstract][Full Text] [Related]
11. Levetiracetam add-on for drug-resistant localization related (partial) epilepsy.
Chaisewikul R; Privitera MD; Hutton JL; Marson AG
Cochrane Database Syst Rev; 2001; (1):CD001901. PubMed ID: 11279737
[TBL] [Abstract][Full Text] [Related]
12. Levetiracetam: a different approach to the pharmacotherapy of epilepsy.
Welty TE; Gidal BE; Ficker DM; Privitera MD
Ann Pharmacother; 2002 Feb; 36(2):296-304. PubMed ID: 11847952
[TBL] [Abstract][Full Text] [Related]
13. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
[TBL] [Abstract][Full Text] [Related]
14. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic profile of levetiracetam: toward ideal characteristics.
Patsalos PN
Pharmacol Ther; 2000 Feb; 85(2):77-85. PubMed ID: 10722121
[TBL] [Abstract][Full Text] [Related]
16. A new antiepileptic drug.
Shorvon SD; van Rijckevorsel K
J Neurol Neurosurg Psychiatry; 2002 Apr; 72(4):426-9. PubMed ID: 11909894
[No Abstract] [Full Text] [Related]
17. Population pharmacokinetics of levetiracetam in Japanese and Western adults.
Pigeolet E; Jacqmin P; Sargentini-Maier ML; Stockis A
Clin Pharmacokinet; 2007; 46(6):503-12. PubMed ID: 17518509
[TBL] [Abstract][Full Text] [Related]
18. Benefit-risk assessment of levetiracetam in the treatment of partial seizures.
Abou-Khalil B
Drug Saf; 2005; 28(10):871-90. PubMed ID: 16180937
[TBL] [Abstract][Full Text] [Related]
19. The KEEPER trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study.
Morrell MJ; Leppik I; French J; Ferrendelli J; Han J; Magnus L
Epilepsy Res; 2003 May; 54(2-3):153-61. PubMed ID: 12837566
[TBL] [Abstract][Full Text] [Related]
20. Preliminary efficacy of levetiracetam in children.
Glauser TA; Dulac O
Epileptic Disord; 2003 May; 5 Suppl 1():S45-50. PubMed ID: 12915341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
